24HourWire

24HourWire

News from all angles

Jacobin Left

The Profit Motive Behind New Alzheimer’s Treatments

Big Pharma and industry-funded advocacy groups are promoting Alzheimer’s blood testing that could label millions of Americans as sick — despite dangerous treatments for early diagnoses of the disease.

Redirecting to Jacobin in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network